Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration

Author:

Reddy Usha1,Krzystolik Magdalena2

Affiliation:

1. c/o Cochrane Eyes and Vision Group US Project; 615 North Wolfe Street Mailbox Room W 5010 Baltimore USA MD 21218

2. Southern New England Retina Associates; 1 Randall Square, Suite 206 Providence USA RI 02703

Publisher

Wiley

Subject

Pharmacology (medical)

Reference27 articles.

1. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial;Pharmacological Therapy for Macular Degeneration Study Group;Archives of Ophthalmology,1997

2. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation;Engler;BJO,1994

3. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration;Poliner;Ophthalmology,1993

4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;New England Journal of Medicine,1994

5. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3;Age-Related Eye Disease Study Research Group;Ophthalmology,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3